CIK 0001125345
- Non-accelerated filer
- Smaller reporting company
MACROGENICS INC
Sign in to watch- Ticker
- MGNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-251-5172
- Business address
- 9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 6,924 shares at $29.38 ($203,427)
- 4 Open-market sale General Counsel sold 68 shares at $30.00 ($2,040)
- 4 Open-market sale Sr VP, BPD & Manufacturing sold 1,770 shares at $30.00 ($53,100)
- 4 Exercise or conversion Sr VP & Chief Business Officer acquired 6,000 shares (option exercise)
- 4 Exercise or conversion SVP, CFO and Secretary acquired 7,326 shares (option exercise)
- 4 Exercise or conversion SVP, CFO and Secretary acquired 5,314 shares (option exercise)
- 4 Exercise or conversion President and CEO acquired 39,897 shares (option exercise)
- 4 Exercise or conversion SVP, CFO and Secretary acquired 5,000 shares (option exercise)
- 4 Exercise or conversion Sr VP & Chief Business Officer acquired 5,000 shares (option exercise)
- 4 Exercise or conversion SVP, CFO and Secretary acquired 3,000 shares (option exercise)
- 4 Exercise or conversion Sr VP & Chief Business Officer acquired 4,000 shares (option exercise)
- 4 Exercise or conversion President and CEO acquired 40,000 shares (option exercise)
- 4 Exercise or conversion Sr VP & Chief Business Officer acquired 3,000 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 14 of 25 · 484 filings